Chronic gastritis
Conditions
Interventions
experiment group:Sodium Azulensulfonate Tablets
control group:Placebo
Sponsors
Gastroenterology department of West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. inpatient or outpatient; 2. aged between 18 to 65 years, no gender limit; 3. clinical or gastroscopic diagnosed with chronic gastritis(active stage); 4. sign the informed consent; 5. agree with the requirements of the research plan and regular assessment.
Exclusion criteria
Exclusion criteria: 1. complicated with peptic ulcer, high grade gastric dysplasia or was suspected malignant; transformation pathologically; 2. diagosed with peptic ulcer and underwent surgery for complication within 30 days, or had a history of gastrectomy, gastrointestinal anastomosis; 3. co-morbidity or complication that may effect efficacy observation or contradict to the experimental drug; 4. serious co-morbidity with heart, brain, lung, liver(liver function: ALT, AST is two times greater than the upper limit, or total bilirubin is 1.5 times greater than the upper limit), kidney(abnormal creatine) or hypertension (level 3 or above; 5. Pregnant, preparing to get pregnant, or nursing mothers; 6. alcoholic, drug addict or other unsuitable participant for drug trial; 7. prone to allergy; 8. participate in other drug trial within 3 months; 9. with the necessity to take drugs (such as acid-inhibitors, mucosa protectant, antibiotic) that may interfere with efficacy observation one week before the trial or within the trial 10. other participants that were considered unsuitable by doctors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| gastroscopic efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| pathological efficacy;symptomatic efficacy; | — |
Countries
China
Contacts
Public ContactTang Chengwei
Outcome results
None listed